Methylene Blue Mouthwash for the Treatment of Oral Mucositis Pain in Patients With Cancer
This phase III trial compares the effect of methylene blue mouthwash to standard of care mouthwash for the treatment of oral mucositis pain in patients with cancer. Using methlylene blue mouthwash may improve oral pain in patients with oral mucositis related to cancer and/or cancer treatments compared to usual standard of care.
Hematopoietic and Lymphoid System Neoplasm|Malignant Solid Neoplasm|Stomatitis
OTHER: Anti-inflammatory/Antimicrobial/Analgesic Aqueous Mouth Rinse|OTHER: Methylene Blue Oral Rinse
Change in oral pain, Pain will be assessed using the standard institutional numeric rating scale where pain level is quantified on a scale of 0 (no pain) to 10 (worst possible pain) pre- and post-intervention (3 times daily for 3 days). Last collected scores will be compared to baseline., Baseline, 3 days
Change in the amount of oral intake, Electronic medical records will be reviewed for demographic and clinical information, medication administration record, and intake and output, Baseline, 3 days|Change in the amount of daily requirements of oral morphine equivalents, Electronic medical records will be reviewed for demographic and clinical information, medication administration record, and intake and output, Baseline, 3 days
This phase III trial compares the effect of methylene blue mouthwash to standard of care mouthwash for the treatment of oral mucositis pain in patients with cancer. Using methlylene blue mouthwash may improve oral pain in patients with oral mucositis related to cancer and/or cancer treatments compared to usual standard of care.